Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester

Details for Australian Patent Application No. 2003251651 (hide)

Owner Novartis AG

Inventors Jordine, Guido; Mutz, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2003251651

PCT Number PCT/EP03/08314

PCT Pub. Number WO2004/013156

Priority 0217504.0 29.07.02 GB

Filing date 28 July 2003

Wipo publication date 23 February 2004

Acceptance publication date 12 July 2007

International Classifications

C07J 33/00 (2006.01) Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 0217504.0 29.07.02 GB

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003251651

12 July 2007 Application Accepted

  Published as AU-B-2003251651

8 November 2007 Standard Patent Sealed

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251652-METHOD FOR PRODUCING PROPENYL OXIDE USING A SECONDARY REACTOR COMPRISING SEVERAL FEED AND/OR OUTLET POINTS

2003251650-ORGANIC COMPOUNDS